Anshen Buxin Liuwei Pills for the Treatment of Cardiac Neurosis

Inclusion Criteria: * Age ≥18 years old, ≤75 years old; * Meet the diagnostic criteria for cardiac neurosis: the patient has palpitations, precordial pain, chest tightness, shortness of breath, dyspnea, dizziness, insomnia and dreaminess, cold hands and feet, hyperhidrosis and other cardiovascular symptoms and neurological disorders; * Meet the diagnostic criteria of Heyisheng type palpitations in Mongolian medicine; * There is no objective diagnosis of coronary heart disease (in accordance with any of the following): ①The activity flat test is negative; ② Coronary angiography or coronary CTA suggests that the lumen stenosis is ≤50%; ③ Exercise or drug load radionuclide examination results suggest no myocardial ischemia; * The patient did not take anti-anxiety and depression drugs or psychotropic drugs within 2 weeks before enrollment; * agrees to voluntarily participate in the study and signs an informed consent form . Exclusion Criteria: * Accompanied by organic heart disease, severe cardiopulmonary insufficiency; * Poor hypertension control (systolic blood pressure ≥160mmHg or diastolic blood pressure ≥100mmHg after treatment); * Those with malignant arrhythmia; * Those who use pacemakers; * Patients with hyperthyroidism; * Combined with severe liver and kidney damage (ALT, AST or TBIL\> 2 times the upper limit of the normal reference value, or Cr\> 1.5 times the upper limit of the normal reference value); * People with serious primary diseases such as hematopoietic system or mental illness; * SAS≥70; * SDS≥73; * Accompanying any other serious diseases or conditions such as malignant tumors; * Women during pregnancy and lactation; * People with allergies or allergies to the known ingredients of the research drug; * Participated in other clinical research in the past 3 months; * According to the judgment of the investigator, the subject is not suitable for research observation.